Lifecore Biomedical
LFCR
LFCR
77 hedge funds and large institutions have $136M invested in Lifecore Biomedical in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
7.12% more ownership
Funds ownership: 65.45% → 72.57% (+7.1%)
3% more capital invested
Capital invested by funds: $132M → $136M (+$3.72M)
0% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 18
Holders
77
Holding in Top 10
5
Calls
$954K
Puts
$509K
Top Buyers
| 1 | +$7.47M | |
| 2 | +$4.84M | |
| 3 | +$1.95M | |
| 4 |
GRIM
Greenhaven Road Investment Management
Greenwich,
Connecticut
|
+$1.07M |
| 5 |
DA
DCF Advisers
Greenwich,
Connecticut
|
+$860K |
Top Sellers
| 1 | -$2.36M | |
| 2 | -$2.16M | |
| 3 | -$1.24M | |
| 4 |
CSC
Cove Street Capital
El Segundo,
California
|
-$1.21M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$676K |